🇺🇸 FDA
Patent

US 9884096

Compositions and methods related to graft versus host disease and treatments thereof

granted A61KA61K2039/505A61K35/39

Quick answer

US patent 9884096 (Compositions and methods related to graft versus host disease and treatments thereof) held by The Regents of the University of Colorado, a Body Corporate expires Mon Feb 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado, a Body Corporate
Grant date
Tue Feb 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K2039/505, A61K35/39, A61K38/191, A61K38/217